“The news is [not] all good”: misrepresentations and inaccuracies in Australian news media reports on prostate cancer screening

Ross MacKenzie, Simon Chapman, Alexandra Barratt and Simon Holding
Med J Aust 2007; 187 (9): 507-510.
  • Ross MacKenzie1
  • Simon Chapman2
  • Alexandra Barratt3
  • Simon Holding4

  • School of Public Health, University of Sydney, Sydney, NSW.

Competing interests:

This study was funded by the Cancer Council NSW, which does not support population screening for prostate cancer. Ross MacKenzie is an employee of the Cancer Council NSW.

  • 1. Ilic D, O’Connor D, Green S, et al. Screening for prostate cancer. Cochrane Database Syst Rev 2006; (3): CD004720.
  • 2. International Union Against Cancer. 3.7 Screening. In: Evidence-based cancer prevention: strategies for NGOs. A UICC handbook for Europe. Geneva: UICC, 2004. http://www. (accessed Jun 2007).
  • 3. US Preventive Services Task Force. Screening for prostate cancer. Rockville, Md: USPSTF, 2002. (accessed Jun 2007).
  • 4. United Kingdom National Health Service. National Screening Committee policy — prostate cancer screening. July 2006. (accessed Jun 2007).
  • 5. Australian Prostate Cancer Collaboration Inc [website]. (accessed Jun 2007).
  • 6. The Cancer Council Australia. Prostate cancer screening position statement. Sydney: Cancer Council Australia, 2005. (accessed Jun 2007).
  • 7. American Cancer Society. Guidelines for the early detection of cancer. Atlanta: ACS, 2007. lines_36.asp (accessed Jun 2007).
  • 8. MacKenzie R, Chapman S, Holding S, McGeechan K. “A matter of faith, not science”: discourse on prostate cancer screening in Australian news media 2003–2006. J R Soc Med 2007. In press.
  • 9. Chapman S, MacKenzie R. The Australian Health News Research Collaboration [letter]. Med J Aust 2007; 186: 326. <MJA full text>
  • 10. Australian Institute of Health and Welfare. Australia’s health 2006. Canberra: AIHW, 2006. (AIHW Cat. No. AUS 73.) (accessed Jul 2007).
  • 11. Urological Society of Australia and New Zealand. PSA testing for prostate cancer. (accessed Jun 2007).
  • 12. Thompson IM, Ankherst DP, Chi C, et al. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower. JAMA 2005; 294: 66-70.
  • 13. Kerlikowske K, Grady D, Barclay J, et al. Likelihood ratios for modern screening mammography: risk of breast cancer based on age and mammographic interpretation. JAMA 1996; 276: 39-43.
  • 14. Australian Institute of Health and Welfare. BreastScreen Australia monitoring report 2000–2001. (AIHW Cancer Series No. 25). Canberra: AIHW, 2003: Tables 30 and 32. (AIHW Cat. No. CAN 20.) (accessed Jul 2007).
  • 15. Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002; 137: 917-929.
  • 16. Morrison AS. Screening in chronic disease. Monographs in epidemiology and biostatistics. Vol. 19. New York: Oxford University Press, 1992.
  • 17. Barratt A, Irwig L, Glasziou P, et al. Users’ guides to the medical literature: XVII. How to use guidelines and recommendations about screening. JAMA 1999; 281: 2029-2034.
  • 18. Draisma G, Boer R, Otto SJ, et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003; 95: 868-878.
  • 19. McDavid K, Melnik TA, Derderian H. Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997. Prev Med 2000; 31: 195-202.
  • 20. Threlfall TJ, English DR, Rouse IL. Prostate cancer in Western Australia: trends in incidence and mortality from 1985 to 1996. Med J Aust 1998; 169: 21-24. <MJA full text>
  • 21. McCaul KA, Luke CG, Roder DM. Trends in prostate cancer incidence and mortality rates in South Australia, 1977–1993. Med J Aust 1995; 162: 520-522.
  • 22. Smith DP, Armstrong BK. Prostate-specific antigen testing in Australia and association with prostate cancer incidence in New South Wales. Med J Aust 1998; 169: 17-20. <MJA full text>
  • 23. Vis AN. Does PSA screening reduce prostate cancer mortality [commentary]? CMAJ 2002; 166: 600-601.
  • 24. Oliver SE, Gunnel D, Donovan JL. Comparison of trends in prostate-cancer mortality in England and Wales and the USA. Erratum in: Lancet 2000; 356: 1278. Lancet 2000; 355: 1788-1789.
  • 25. Perron L, Moore L, Bairati I, et al. PSA screening and prostate cancer mortality. CMAJ 2002; 166: 586-591.
  • 26. Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002; 347: 781-789.
  • 27. Potosky AL, Davis WW, Hoffman RM. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2004; 96: 1358-1367.
  • 28. da Vinci [website]. Hospitals and doctors. (accessed Jul 2007).
  • 29. Patel VR, Chammas Jr MF, Shah S. Robotic assisted laparoscopic radical prostatectomy: a review of the current state of affairs. Int J Clin Pract 2007; 61: 309-314.
  • 30. Rassweiler J, Hruza M, Teber D, et al. Laparoscopic and robotic assisted radical prostatectomy — critical analysis of the results. Eur Urol 2006; 49: 612-624.
  • 31. Maddern GJ. Robotic surgery: will it be evidence-based or just “toys for boys” [editorial]? Med J Aust 2007; 186: 221-222. <MJA full text>
  • 32. McCammon K, Kolm P, Main B. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology 1999; 54: 509-516.
  • 33. Steineck G, Helgesen F, Adolfsson J, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002; 347: 790-796.
  • 34. Trevena LJ, Davey HM, Barratt A, et al. A systematic review on communicating with patients about evidence. J Eval Clin Pract 2006; 12: 13-23.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.